Index
1 Market Overview
1.1 Product Overview and Scope of Multicancer Detection
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Multicancer Detection by Type
1.3.1 Overview: Global Multicancer Detection Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Multicancer Detection Consumption Value Market Share by Type in 2022
1.3.3 Laboratory Developed Tests (LDTs)
1.3.4 In-Vitro Diagnostics (IVDs)
1.4 Global Multicancer Detection Market by Application
1.4.1 Overview: Global Multicancer Detection Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Multicancer Detection Market Size & Forecast
1.6 Global Multicancer Detection Market Size and Forecast by Region
1.6.1 Global Multicancer Detection Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Multicancer Detection Market Size by Region, (2018-2029)
1.6.3 North America Multicancer Detection Market Size and Prospect (2018-2029)
1.6.4 Europe Multicancer Detection Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Multicancer Detection Market Size and Prospect (2018-2029)
1.6.6 South America Multicancer Detection Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Multicancer Detection Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Agilent Technologies, Inc.
2.1.1 Agilent Technologies, Inc. Details
2.1.2 Agilent Technologies, Inc. Major Business
2.1.3 Agilent Technologies, Inc. Multicancer Detection Product and Solutions
2.1.4 Agilent Technologies, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.2 Atara Biotherapeutics, Inc.
2.2.1 Atara Biotherapeutics, Inc. Details
2.2.2 Atara Biotherapeutics, Inc. Major Business
2.2.3 Atara Biotherapeutics, Inc. Multicancer Detection Product and Solutions
2.2.4 Atara Biotherapeutics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Atara Biotherapeutics, Inc. Recent Developments and Future Plans
2.3 Burning Rock DX
2.3.1 Burning Rock DX Details
2.3.2 Burning Rock DX Major Business
2.3.3 Burning Rock DX Multicancer Detection Product and Solutions
2.3.4 Burning Rock DX Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Burning Rock DX Recent Developments and Future Plans
2.4 Danaher Corporation
2.4.1 Danaher Corporation Details
2.4.2 Danaher Corporation Major Business
2.4.3 Danaher Corporation Multicancer Detection Product and Solutions
2.4.4 Danaher Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Danaher Corporation Recent Developments and Future Plans
2.5 Exact Sciences Corporation
2.5.1 Exact Sciences Corporation Details
2.5.2 Exact Sciences Corporation Major Business
2.5.3 Exact Sciences Corporation Multicancer Detection Product and Solutions
2.5.4 Exact Sciences Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Exact Sciences Corporation Recent Developments and Future Plans
2.6 Hoffmann-La Roche Ltd
2.6.1 Hoffmann-La Roche Ltd Details
2.6.2 Hoffmann-La Roche Ltd Major Business
2.6.3 Hoffmann-La Roche Ltd Multicancer Detection Product and Solutions
2.6.4 Hoffmann-La Roche Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.7 Fulgent Genetics.
2.7.1 Fulgent Genetics. Details
2.7.2 Fulgent Genetics. Major Business
2.7.3 Fulgent Genetics. Multicancer Detection Product and Solutions
2.7.4 Fulgent Genetics. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Fulgent Genetics. Recent Developments and Future Plans
2.8 Genecast Biotechnology Co., Ltd
2.8.1 Genecast Biotechnology Co., Ltd Details
2.8.2 Genecast Biotechnology Co., Ltd Major Business
2.8.3 Genecast Biotechnology Co., Ltd Multicancer Detection Product and Solutions
2.8.4 Genecast Biotechnology Co., Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Genecast Biotechnology Co., Ltd Recent Developments and Future Plans
2.9 Guardant Health, Inc.
2.9.1 Guardant Health, Inc. Details
2.9.2 Guardant Health, Inc. Major Business
2.9.3 Guardant Health, Inc. Multicancer Detection Product and Solutions
2.9.4 Guardant Health, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Guardant Health, Inc. Recent Developments and Future Plans
2.10 Illumina, Inc.
2.10.1 Illumina, Inc. Details
2.10.2 Illumina, Inc. Major Business
2.10.3 Illumina, Inc. Multicancer Detection Product and Solutions
2.10.4 Illumina, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Illumina, Inc. Recent Developments and Future Plans
2.11 Konica Minolta, Inc.
2.11.1 Konica Minolta, Inc. Details
2.11.2 Konica Minolta, Inc. Major Business
2.11.3 Konica Minolta, Inc. Multicancer Detection Product and Solutions
2.11.4 Konica Minolta, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Konica Minolta, Inc. Recent Developments and Future Plans
2.12 Laboratory Corporation of America Holdings.
2.12.1 Laboratory Corporation of America Holdings. Details
2.12.2 Laboratory Corporation of America Holdings. Major Business
2.12.3 Laboratory Corporation of America Holdings. Multicancer Detection Product and Solutions
2.12.4 Laboratory Corporation of America Holdings. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Laboratory Corporation of America Holdings. Recent Developments and Future Plans
2.13 Myriad Genetics, Inc.
2.13.1 Myriad Genetics, Inc. Details
2.13.2 Myriad Genetics, Inc. Major Business
2.13.3 Myriad Genetics, Inc. Multicancer Detection Product and Solutions
2.13.4 Myriad Genetics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Myriad Genetics, Inc. Recent Developments and Future Plans
2.14 Tempus
2.14.1 Tempus Details
2.14.2 Tempus Major Business
2.14.3 Tempus Multicancer Detection Product and Solutions
2.14.4 Tempus Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Tempus Recent Developments and Future Plans
2.15 Thermo Fisher Scientific Inc.
2.15.1 Thermo Fisher Scientific Inc. Details
2.15.2 Thermo Fisher Scientific Inc. Major Business
2.15.3 Thermo Fisher Scientific Inc. Multicancer Detection Product and Solutions
2.15.4 Thermo Fisher Scientific Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Multicancer Detection Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Multicancer Detection by Company Revenue
3.2.2 Top 3 Multicancer Detection Players Market Share in 2022
3.2.3 Top 6 Multicancer Detection Players Market Share in 2022
3.3 Multicancer Detection Market: Overall Company Footprint Analysis
3.3.1 Multicancer Detection Market: Region Footprint
3.3.2 Multicancer Detection Market: Company Product Type Footprint
3.3.3 Multicancer Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Multicancer Detection Consumption Value and Market Share by Type (2018-2023)
4.2 Global Multicancer Detection Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Multicancer Detection Consumption Value Market Share by Application (2018-2023)
5.2 Global Multicancer Detection Market Forecast by Application (2024-2029)
6 North America
6.1 North America Multicancer Detection Consumption Value by Type (2018-2029)
6.2 North America Multicancer Detection Consumption Value by Application (2018-2029)
6.3 North America Multicancer Detection Market Size by Country
6.3.1 North America Multicancer Detection Consumption Value by Country (2018-2029)
6.3.2 United States Multicancer Detection Market Size and Forecast (2018-2029)
6.3.3 Canada Multicancer Detection Market Size and Forecast (2018-2029)
6.3.4 Mexico Multicancer Detection Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Multicancer Detection Consumption Value by Type (2018-2029)
7.2 Europe Multicancer Detection Consumption Value by Application (2018-2029)
7.3 Europe Multicancer Detection Market Size by Country
7.3.1 Europe Multicancer Detection Consumption Value by Country (2018-2029)
7.3.2 Germany Multicancer Detection Market Size and Forecast (2018-2029)
7.3.3 France Multicancer Detection Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Multicancer Detection Market Size and Forecast (2018-2029)
7.3.5 Russia Multicancer Detection Market Size and Forecast (2018-2029)
7.3.6 Italy Multicancer Detection Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Multicancer Detection Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Multicancer Detection Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Multicancer Detection Market Size by Region
8.3.1 Asia-Pacific Multicancer Detection Consumption Value by Region (2018-2029)
8.3.2 China Multicancer Detection Market Size and Forecast (2018-2029)
8.3.3 Japan Multicancer Detection Market Size and Forecast (2018-2029)
8.3.4 South Korea Multicancer Detection Market Size and Forecast (2018-2029)
8.3.5 India Multicancer Detection Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Multicancer Detection Market Size and Forecast (2018-2029)
8.3.7 Australia Multicancer Detection Market Size and Forecast (2018-2029)
9 South America
9.1 South America Multicancer Detection Consumption Value by Type (2018-2029)
9.2 South America Multicancer Detection Consumption Value by Application (2018-2029)
9.3 South America Multicancer Detection Market Size by Country
9.3.1 South America Multicancer Detection Consumption Value by Country (2018-2029)
9.3.2 Brazil Multicancer Detection Market Size and Forecast (2018-2029)
9.3.3 Argentina Multicancer Detection Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Multicancer Detection Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Multicancer Detection Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Multicancer Detection Market Size by Country
10.3.1 Middle East & Africa Multicancer Detection Consumption Value by Country (2018-2029)
10.3.2 Turkey Multicancer Detection Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Multicancer Detection Market Size and Forecast (2018-2029)
10.3.4 UAE Multicancer Detection Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Multicancer Detection Market Drivers
11.2 Multicancer Detection Market Restraints
11.3 Multicancer Detection Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Multicancer Detection Industry Chain
12.2 Multicancer Detection Upstream Analysis
12.3 Multicancer Detection Midstream Analysis
12.4 Multicancer Detection Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer